Giant cell arteritis: Diagnosing and treating inflammatory disease in older adults

Geriatrics

Volumn 60, Issue 8, 2005, Pages 26-30

  Azhar, Syed S ^a   Tang, Rosa A ^a,b   Dorotheo, E Ulysses ^a   Sherman, ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Department of Ophthalmology ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cranial arteritis granulomatous arteritis; Giant cell arteritis; Steroids; Temporal arteritis; Visual loss

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 6;

AGED; BLINDNESS; BLOOD VESSEL BIOPSY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; EYE DISEASE; FATIGUE; GERIATRIC PATIENT; GIANT CELL ARTERITIS; HEADACHE; HUMAN; LABORATORY TEST; NECROTIZING ARTERITIS; REVIEW; STEROID THERAPY; SYSTEMIC THERAPY; TEMPORAL ARTERITIS; TEMPORAL ARTERY;

AGED; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PHYSICAL EXAMINATION; PREDNISOLONE; TEMPORAL ARTERITIS;

EID: 23844499959     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. In: Kelly WM, et al., eds. Textbook of Rheumatology. 5th ed. Philadelphia: Saunders; 1997:1123-32.
2. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981; 24(7):899-904.
3. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted county, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123(3):192-4.
4. Dababneh A, Gonzales-Gay MA, Garcia-Porrua C, Hajeer A, Thompson W, Oilier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA Class II association. J Rheumatol 1998; 25(11):2140-5.
5. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122-8; accessed 7/10/05 at http://www.rheumatology. org/publicatio ns/classification/tca.asp?aud=mem
6. Hunder G. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 1998; 129(5):417-8.
7. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002; 287(1):92-101.
8. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972; 77(6):845-52.
9. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97(5):672-80.
10. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125(4):509-20.
11. Keltner JL. Giant cell arteritis. Signs and symptoms. Ophthalmology 1982; 89(10):1101-10.
12. Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967; 2:85-7.
13. Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000; 43(5):1041-8.
14. Hayre SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123(3):285-96.
15. Hayreh SS. Anterior ischemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. Eye 1990; 4(Pt 1):25-41.
16. McDonnell PJ, Moore GW, Miller NR, Hutchins GM, Green WR. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986; 93(4):518-30.
17. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2003; 347(4):261-71.
18. Spiera R, Spiera H. Inflammatory disease in older adults: Cranial arteritis. Geriatrics 2004; 59(Dec):25-29.
19. Schmidt D, Vaith P, Hetzel A. Prevention of serious ophthalmic and cerebral complications in temporal arteritis? Clin Exp Rheumatol 2000; 18(4 suppl 20):S61-3.
20. Andersson R, Malmvall BE, Bengtsson BA. Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986; 220(5):465-9.
21. Weyand CM, Kaiser M, Yang H, Younge B, Goronzy JJ. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 2002; 46(2):457-66. http://www.ncbi.nlm. nih.gov/entrez/query.fcgi?cmd=Retrieve &db=pubmed&dopt=Abstract&list_uids =11840449&query_hl=1